Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)

Marcus Lind; Irl B. Hirsch; Jaakko Tuomilehto; Sofia Dahlqvist; Bo Åhrén; Ole Torffvit; Stig Attvall; Magnus Ekelund; Karin Filipsson; Bengt-Olov Tengmark; Stefan Sjöberg; Nils-Gunnar Pehrsson

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)

Marcus Lind(University of Gothenburg), Irl B. Hirsch(University of Washington), Jaakko Tuomilehto(Universität für Weiterbildung Krems), Sofia Dahlqvist(NU Hospital Group), Bo Åhrén(Lund University), Ole Torffvit(Lund University), Stig Attvall(University of Gothenburg), Magnus Ekelund(Lund University), Karin Filipsson(Lund University), Bengt-Olov Tengmark(Barndiabetesfondens), Stefan Sjöberg(Karolinska University Hospital), Nils-Gunnar Pehrsson

STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)

January 1, 2015

Cited by 0

Abstract

What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple daily insulin injections?

Related Papers

No related papers found

Powered by citation graph analysis